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The vaginal and rectal mucosae are the first line of cellular immune defense to sexually transmitted human immunodeficiency virus type 1
(HIV-1) entry. Thus, intraepithelial lymphocytes (IELs) may be important in the immune response to HIV infection. Here we investigated
whether functional IELs in mucosal compartments could be visualized by direct staining with a tetrameric complex specific for the simian
immunodeficiency virus (SIV) immunodominant Gag epitope in either separated IEL cells or tissues of macaques infected with SIVmac251.
Of the 15 Mamu-A*01-positive macaques studied here, eight were chronically infected with either SIVmac251 or simian–human
immunodeficiency virus (SHIV) KU2 and the remaining seven were exposed mucosally to SIVmac251 and sacrificed within 48 h to assess
the local immune response. Gag-specific CD8+ T-cells were found in separated IELs from the rectum, colon, jejunum, and vagina of most
infected animals. Direct staining of tetramers also revealed their presence in intact tissue. These Gag-specific IELs expressed the activation
marker CD69 and produced IFN-g, suggesting an active immune response in this locale.
Published by Elsevier Inc.Keywords: CD8+ IELs; SIVmac infection; Mucosal compartmentsIntroduction
The assessment of immune responses to HIV at entry
sites is important because mucosal sites are the targets of
HIV infection. Some studies have shown that HIV-1 can be
rapidly internalized by intestinal epithelial cells, transcy-
tosed toward the basolateral pole of the cell, and released in
its infectious form (Bomsel, 1997; Hocini and Bomsel,
1999). Other studies have demonstrated that HIV can cross
the intact stratified epithelia of vagina, exocervix, foreskin,
and anus probably by infecting processes of dendritic cells
that extend into the lumen (Fantini et al., 1997; Hu et al.,
2000; Spira et al., 1996).0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2003.08.046
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1 Fax: +1-985-871-6569.Therefore, the presence of immune cells at these sites
may help to contain viral replication early on, as a recent
study has suggested (Belyakov et al., 2001). Key compo-
nents of mucosal defense against infection include muco-
sal IgA, the anti-invasive glycocalyx of the mucosae, and
the intraepithelial lymphocytes (IELs) (Lefrancois, 1999).
IELs are a population of predominantly CD3+CD8+ T-
cells interspersed within the epithelial layer and thus
directly exposed to outside antigens (Lefrancois, 1999).
Therefore, at mucosal sites, IELs represent the first
available cellular line of defense against the virus. In
humans, the IEL population is heterogeneous and differ-
ences among IELs are present along the length of the
intestine. In the intestine of nonhuman primates, g/y T-
cell-receptor (TCR)-positive CD3+CD8+ IELs represent
only 5% of the total population and do not participate in
typical cytotoxic T-lymphocyte (CTL) activity (Mattapallil
et al., 1998). Other cells present are a/a TCR CD8+ T-
cells that are mainly CD4+CD8+ double-positive cells
that decrease during infection (Mattapallil et al., 2000)
Table 1
Time from infection and CD4+ T-cell counts in chronically infected Mamu-
A*01-positive macaques
Macaque Time of
infection
(weeks)
Virus CD3+CD4+
T-cell count
RNA copies/ml
plasma at time of
tissue collection
409 129 SHIV KU2 1234 <20000
450 103 SIVmac251 1165 <20000
3218 16 SIVmac251 909 Not available
3248 23 SIVmac251 345 Not available
454 156 SHIV KU2 781 <20000
455 156 SHIV KU2 956 <20000
460 127 SIVmac251 684 56290
649 124 SIVmac251 1476 401110
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activity. a/h TCR CD8+ T-cells were also shown to be
the main population in the vaginal epithelium of mac-
aques (Lohman et al., 1995).
CTL activity of IELs was previously described in the
vaginal epithelium and in the small intestine epithelium ofFig. 1. Frequency of Gag181 – 189 CM9 tetramer-positive cells in the IEL population
IELs from the colon, rectal, and vaginal mucosae of chronically infected macaq
through the CD3+CD8+ population, and quadrant analysis was performed for ex
acquired for each analysis.simian immunodeficiency virus (SIV) chronically infected
macaques (Couedel-Courteille et al., 1997; Lohman et al.,
1995). SIV Gag- and Env-specific CTL activity was
detected in primary cultures of IELs from macaques
infected with SIV for 1, 2, and 4 weeks (Mattapallil et
al., 1998), and in the same study a decrease of CD4+ IELs
was also observed. A follow-up study showed that the
decreased CD4+ IEL population consisted of double-pos-
itive CD8a/a+CD4+ cells. This was accompanied by an
increase of CD8a/h+ IELs that are considered to be mature
cells capable of mounting a CTL response (Mattapallil et
al., 2000). However, all of these studies were done on
cultured cells derived from IELs. Here we assessed the
frequency of antigen-specific CD3+CD8a/h+ IELs in the
jejunum, colon, and rectum as well as from the vaginal
epithelium of SIVmac-infected macaques using the tetra-
mer technology. Direct visualization of tetramer-positive
SIV Gag-specific IELs (Altman et al., 1996) within the
colon was also performed by in situ tetramer staining on
tissues.of chronically SIVmac251- or SHIV KU2-infected macaques. SIV-specific
ues described in Table 1. Three-color staining was done, cells were gated
pression of Gag181 – 189 CM9 and CD8. CD3+CD8+ cells (1  104) were
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High frequency of SIV Gag-specific CD8+ lymphocytes in
the intraepithelial compartment of chronically
SIVmac251- or SHIV KU2-infected macaques
We and others have previously shown that CD3+CD8+
T-cells recognizing the dominant Gag181–189CM9 (p11c)
peptide can be found not only in blood and lymphoid organs
but also in the gut-associated lymphoid tissue (GALT) and
lamina propria of Mamu-A*01-positive macaques during
both primary and long-standing SIVmac infection (Hel et
al., 2001; Imaoka et al., 1998; Murphey-Corb et al., 1999;
Stevceva et al., 2001, 2002a, 2002b). Here, we assessed the
relative frequency of CD8a/h+ lymphocytes, specific for
the immunodominant SIVmac peptide Gag81–189CM9, in
the intraepithelial compartment of colon, jejunum, rectal,
and vaginal mucosae in eight Mamu-A*01-positive mac-
aques with longstanding SIVmac251 infection. Most of
these animals had CD4+ T-cell counts within a normal
range (Table 1) and were able to naturally control viral
replication (i.e., plasma virus levels were less than 2000
copies/100 Al of plasma input), as previously reported (Pal
et al., 2001). The percentage of CD3+CD8a/h+Gag181–
189CM9-positive tetramer-staining cells in the IELs isolated
from colon, rectum, and vagina varied among animals andFig. 2. In situ tetramer staining for Gag181 – 189 CM9-specific IELs. Images for ind
hand side. Differential interface contrast and gray scale are shown on the bottom
lamina propria, is labeled with a blue line. A merged image, containing all three c
also positive for the Gag181 – 189 CM9 tetramer is labeled with an arrow. FITC, flin some cases was as high as 8% of the total CD3+CD8+ T-
cells present in these compartments, as demonstrated for
three of the eight macaques in Fig. 1.
To confirm the location of Gag tetramer-positive cells
within the intact epithelial layer, in situ tetramer staining
was performed on ex vivo intestinal tissues from chronically
infected macaque 649. As demonstrated in Fig. 2, a portion
of CD3+ T-cells was also stained by the Gag181–189CM9
tetramer, confirming their presence in the intact intestinal
epithelial layer.
Functionality of Gag-specific CD8+ IELs
To assess the activation status of total and Gag-specific
CD8+ T-cells in the mucosal compartments of these animals,
cells were stained with an Ab that recognizes the CD69
activation marker. As demonstrated in Fig. 3A, most of the
IEL cells in jejunum, colon, rectum, and vagina from mac-
aques 460, 455, 454, 409, and 450 stained positive for CD69,
demonstrating their activation status (Fig. 3A). A similar
analysis of the Gag181–189CM9-specific population in ani-
mals 450 and 409 demonstrated that most of these virus-
specific CD8+ T-cells expressed the CD69 marker, indicating
that the SIV-specific population of CD8a/h+IELs had an
activated phenotype in colon, rectum, and vagina (Fig. 3A).
These data agree with observations by others (Couedel-ividual channels (CD3, green; SIV Gag tetramer, red) are shown on the left-
right panel. The basal membrane, separating the epithelial layer from the
hannels, is shown on the top right panel. An example of a CD3+ IEL that is
uorescein isothyocyanate, CY3, indocarbocyanine.
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1998) and go along with the demonstration by others of IEL
cytolytic activity. In contrast, the expression of CD25 was
very low, both on the CD3+CD8+ IEL population as well as
on the Gag181–189CM9-specific IELs (data not shown).Fig. 3. Activation status and functionality of IEL and lamina propria CD8a/h+ T
infected macaques. Cells were gated through the CD3+CD8+ population and the
CD69. Following unspecific stimulation with PMA and ionomycin, expression of I
from the same macaque. Raw data are demonstrated for macaques 3218 and 3248 i
intracellular cytokine staining revealed fairly low expression of the IL-10 cyto
producing IFN-g.To assess the ability of IELs to produce cytokines, in
vitro stimulation with lipopolysaccharide (LPS), PMA/ion-
omycin, or the GagGag181–189CM9 peptide was performed
on cells from the IELs or lamina propria from various
compartments. The cells were stained for intracellular-cells. (A) Four-color staining was done on isolated IELs from chronically
n quadrant analysis was performed for expression of Gag181 – 189 CM9 and
FN-g was higher in the IELs (B) than in the lamina propria lymphocytes (C)
n the bottom panels of the figure. (D) Following 24-h stimulation with LPS,
kine. (E) Percentage of Gag181 – 189 CM9-specific tetramer-positive cells
Fig. 3 (continued).
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h+ IELs produced IFN-g following PMA and ionomycin
stimulation, demonstrating their viability (Fig. 3B). The
percentage of CD8a/h+ IELs that produced IFN-g was
generally higher in the intraepithelial compartment than in
the lamina propria (Fig. 3C). In contrast, following LPS
stimulation, a much smaller percentage (4–19%) of IEL
cells produced IL-10, a cytokine that is believed to be
involved in peripheral tolerance (Chen et al., 1995; Dallman
et al., 1993; Enk et al., 1993) (Fig. 3D).
Following antigen-specific stimulation, very few if any
of the CD3+CD8+GagGag181–189CM9-positive cells se-
creted IL-10 (range: 0.03–0.28%) (data not shown),
whereas a higher proportion of these cells produced IFN-
g (Fig. 3E). The finding that only a small fraction of
GagGag181–189CM9-specific IEL cells produced IFN-g
upon antigen-specific stimulation may relate to the low
percentage of IELs expressing the co-stimulatory mole-
cules CD28 and CD49d, as reported by others (Couedel-
Courteille et al., 1997; Gelfanov et al., 1995; Reimann and
Rudolphi, 1995; Sillett et al., 1999).
Antigen-specific IELs in the mucosae of vaccinated
macaques following SIVmac251 exposure
We have previously demonstrated that NYVAC-SIV-gag-
pol-env (gpe) immunization of naive macaques by mucosal
or systemic routes can induce virus-specific CD8+ T-cells
that traffic to the lamina propria (Stevceva et al., 2002a,
2002b) and that these cells are expanded following virusencounter. Because we wished to address whether viral
exposure could induce virus-specific IEL responses, the
same macaques immunized with the highly attenuated
recombinant NYVAC-SIV-gpe vaccine candidate by various
routes were exposed to SIVmac251 (Stevceva et al., 2002a,
2002b) (Table 2). Animal 654 was not immunized before
viral exposure and was challenged intrarectally together
with animals 815, 582, 536, 818, and 814, as previously
described (Stevceva et al., 2002a, 2002b). All animals were
sacrificed at 48 h post-challenge and the frequency of
GagGag181– 189CM9-specific tetramer-positive cells was
measured in purified IELs. Tetramer-positive CD3+CD8+
IEL cells were observed in all macaques previously immu-
nized with NYVAC-SIV-gpe but not in the unimmunized
macaque 654 (Fig. 4). These data suggest the possibility that
prior vaccination induced not only Gag-specific tetramer-
positive cells in the lamina propria (Stevceva et al., 2002a,
2002b) but also IELs with the same specificity and that their
frequency may be higher in immunized macaques as a result
of the secondary stimulation induced by viral exposure.Discussion
Developing a successful HIV vaccine may be greatly
hindered by the difficulties in obtaining strong and durable
immune responses at the sites of viral entry, including
vaginal and rectal mucosae. Protection studies with vaccine
candidates have so far shown only partial protection upon
mucosal challenge (Belyakov et al., 2001; Benson et al.,
Fig. 3 (continued).
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2002; Lu et al., 1998). Efforts to obtain immune response by
immunization have been focused on other arms of the
immune response at mucosal surfaces, such as lamina
propria lymphocytes and the readily inducible IgG andIgA responses. Very little attention has been paid to the
antigen-specific IELs that are ideally located at mucosal
surfaces to intercept the virus and limit its spreading.
Previous studies have demonstrated cytotoxic activity in
cultured lymphocytes isolated from cervicovaginal mucosae
Table 2
Immunization history of some of the Mamu-A*01-positive macaques
Macaque Immunogen/route CD3+CD4+
T-cell count
536 NYVAC-SIV-gpe/intramuscular 1668
815 NYVAC-SIV-gpe/intramuscular 2491
814 NYVAC-SIV-gpe/intrarectal 1441
818 NYVAC-SIV-gpe/intrarectal 1269
582 NYVAC-SIV-gpe/intranasal 917
654 None 1300
L. Stevceva et al. / Virology 319 (2004) 190–200196(Lohman et al., 1995) and intestinal epithelia (Mattapallil et
al., 1998). However, direct demonstration of their presence
at these sites has not been provided.
Here, by using the tetramer technology, we were able to
detect the presence of SIV Gag-specific lymphocytes in the
intraepithelial compartment of intestinal and vaginal muco-
sae on isolated IELs and in tissues of SIVmac251- or
simian–human immunodeficiency virus (SHIV) KU2-Fig. 4. Detection of Gag-specific CD8a/h+ T-cells early in post-viral exposure. In
tetramer was below 1%. CD3+CD8+ Gag181 – 189 CM9-positive IELs were found
SIVmac251 challenge (536, 582, and 815). Isolated IELs were initially gated throug
positive cells is shown in the upper right quadrant. CD3+CD8+ cells (1  104) winfected macaques. Furthermore, we demonstrated that these
cells are activated and able to secrete IFN-g.
The generation of Ag-specific IELs that exert cytotoxic
activity upon ex vivo isolation has been reported in studies
by others in SIV-infected macaques as well as in other
infections such as rotavirus (Dharakul et al., 1990; Offit and
Dudzik, 1989) and lymphocytic choriomeningitis virus
(LCMV) (Muller et al., 2000; Sydora et al., 1996). Studies
in mice have demonstrated that Ag-specific IELs are capa-
ble of inducing protective immunity. Passive transfer of
isolated primed IELs from mice infected with Toxoplasma
gondii cysts containing bradyzoites provides long-term
protection by reducing the cyst numbers and results in
survival of all mice if transferred 6–9 days postinfection
(Lepage et al., 1998). The protective cells were shown to be
CD8a/h+ (Buzoni-Gatel et al., 1997). Furthermore, in this
model, it has been demonstrated that it is possible to induce
these protective IELs by intranasal immunization with the
SAG1 protein of T. gondii (Velge-Roussel et al., 2000).the naive macaque 654, the IEL level detected with the Gag181 – 189 CM9
in the cervicovaginal and intestinal tissues of macaques immunized before
h the CD3+CD8+ population. Percentage of CD3+CD8+ Gag181 – 189 CM9-
ere acquired for each analysis.
L. Stevceva et al. / VirologySimilarly, gut CD4+ IELs were shown to be able to induce
protection against Cryptosporidium muris when adoptively
transferred to immunocompromised SCID mice (McDonald
et al., 1996). In both of these cases, protection was shown to
be mediated by IFN-g (Buzoni-Gatel et al., 1997; Culshaw
et al., 1997).
The results of the present study demonstrate the
presence of SIV Gag-specific IELs in ex vivo samples
of nonhuman primates infected with a lentivirus related to
HIV-1. Furthermore, we have shown that SIV Gag-spe-
cific IELs are activated and able to secrete high levels of
IFN-g, a cytokine that has been related to protection
(Heeney et al., 1998; Kuhn et al., 2001). Others have
shown that in SIVmac infection virus-specific IELs are
able to lyse cells expressing the SIVmac Gag and Env
antigens (Couedel-Courteille et al., 1997; Lohman et al.,
1995; Mattapallil et al., 1998). Even though it has been
shown that the tetramer-binding assay detects more HIV-
specific CD8+ T-cells than other methods (Sun et al.,
2003) and that not all tetramer-binding cells seem to
produce IFN-g (Appay et al., 2000; Goepfert et al.,
2000; Hel et al., 2001; Shankar et al., 2000), it does
not require expansion of cells in culture and can be
performed on a few cells. Thus, in light of these findings,
quantitation of Ag-specific IELs at mucosal sites may
become a feasible assay in vaccination studies and con-
tribute to the understanding of correlates of protection or
viremia containment.Materials and methods
Animals and procedure
A total of 14 Mamu-A*01-positive rhesus macaques
(Macaca mulatta) were studied. Five animals (450, 3218,
3248, 460, and 649) were chronically infected with SIV-
mac251 (Pal et al., 2001) and three animals (409, 454, and
455) with SHIV KU2, a chimeric virus that expresses the
SIVmac Gag protein (Table 1). Of the remaining six
macaques, five (815, 536, 582, 814, and 818) were first
immunized with NYVAC-SIV-gpe, exposed to SIVmac251
(561), and sacrificed 48 h later (Stevceva et al., 2002a,
2002b) (Table 2), and one, 654, was unimmunized and
exposed to SIVmac251 at the same time. Among the latter
group of animals, macaques 536 and 815 were first immu-
nized with three inoculations of 1  108 pfu of NYVAC-
SIV-gpe by the intramuscular route. Animal 582 was im-
munized intranasally and animals 814 and 818 were immu-
nized intrarectally with three inoculations of 5  108 pfu of
NYVAC-SIV-gpe. All six immunized macaques and a
control naive macaque (654) were exposed to undiluted
SIVmac251 (561) (Pal et al., 2001) by the intrarectal route
and sacrificed 48 h after infection (Stevceva et al., 2002a,
2002b). Tissues were collected postmortem in RPMI/10%
FBS and IELs were isolated as described below.Isolation of tissue lymphocytes
Mononuclear cells were isolated from intestines, vagina,
and cervix. Tissues from jejunum, colon, rectum, vagina, and
cervix were treated with 1 mM DTT (ICN Biomedicals Inc.,
Aurora, OH) for 30 min followed by incubation in calcium/
magnesium-free HBSS (Life Technologies, Baltimore, MD)
three (intestines) to four (vagina and cervix) times for 1 hwith
stirring at room temperature to remove the epithelial layer. At
this stage, pieces of tissue were fixed in 10% neutral formalin,
embedded in paraffin, and sections cut and stained with H and
E. We performed microscopic examination of the samples to
ensure that most of the epithelium was removed and the
lamina propria was intact. IELs were further purified by
Percoll density gradient centrifugation.
Lamina propria lymphocytes were isolated following
cutting of tissues into smaller pieces and incubated at 37
jC in Isocove’s medium supplemented with 10% FCS and
penicillin/streptomycin containing 400 U/ml Collagenase D
(Boehringer Mannheim GmbH, Mannheim, Germany) and
25 U/ml DNAse (Worthington Biochemical Corporation,
Lakewood, NJ) for 2–3 h. Vaginal and cervical tissues were
digested by using Collagenase type IV (Sigma, St. Louis,
MO). The mononuclear cells were isolated from the super-
natant containing dissociated cells by Percoll gradient
centrifugation.
Phenotypic characterization and flow cytometry
Phenotypic characterization was done by direct three-
and four-color staining of freshly isolated IELs using a panel
of Abs in conjunction with the tetrameric complexes (see
Table 2). Staining with unrelated tetramer and of cells
isolated from Mamu-A*01-negative or naive animals was
used as a negative control. Staining in conjunction with
CD4PE (Becton Dickinson, San Jose, CA) was used as a
positive control.
Briefly, 5  105 lymphocytes isolated by Ficoll diatri-
zoate or Percoll gradient centrifugation were incubated with
2 Ag of tetrameric complexes or selected Abs for 30 min at
room temperature. After washing the cells twice in Dulbec-
co’s phosphate-buffered saline supplemented with 2% FCS
and fixation in 1% paraformaldehyde (Ph = 7.4), samples
were analyzed by flow cytometry using the CellQuest
software (CellQuest, Clearwater, FL) and the FACScalibur
(Becton Dickinson) instrument.
Antigen-specific stimulation of IFN-c and IL-10 in IEL cells
Isolated IELs in 10% FBS, penicillin/streptomycin RPMI
were incubated for 4 h at 37 jC in 48-well plates at a
concentration of 2  106 cells/well and were activated by
adding either the Gag-specific peptide GagGag181–189CM9
as described (Stevceva et al., 2002a, 2002b) in the presence
of 1 Al/ml Golgiplug (Pharmingen, San Diego, CA) or 25
ng/ml PMA and 1 Ag/ml ionomycin. To stimulate IL-10
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RPMI were incubated for 12 h at 37 jC in 48-well plates
at a concentration of 2  106 cells/well in the presence of 1
ng/ml of LPS and 1 Al/ml Golgiplug. Cells were than
stained first with surface Abs and then for intracellular IL-
10 (BD Pharmingen) or IFN-g (BD Pharmingen) by using
Cytofix/Cytoperm Plus kit (Pharmingen) according to the
manufacturer’s instructions. HICK-1 cells (Pharmingen)
were used as a positive control for IFN-g and HICK-2
(Pharmingen) for IL-10. Unstimulated cells and cells stained
only with surface markers or cells stained with isotype
control were used as negative controls. Reading and flow-
cytometric analysis were done using the CellQuest software
and the FACScalibur (Becton Dickinson) instrument.
Tetramer staining in situ
In situ tetramer staining was performed on fresh tissues as
previously described with some modifications (Haanen et al.,
2000; Schmitz et al., 2001; Skinner et al., 2000; Stevceva et
al., 2002a, 2002b). Briefly, tissues were collected by pinch
biopsy, washed in cold PBS, and cut into small strips. The
resulting sections (n = 4–6) were then incubated with 10 Al/
section of antigen-specific tetramer labeled with Cy3 (Amer-
sham, Piscataway, NJ) and gently agitated at 37 jC for 15
min. The tissue was then rinsed repeatedly at 37 jC with
PBS and then twice with ice-cold PBS before fixation with
cold 2% paraformaldehyde for 20 min. After additional
washes, Abs to CD3 (Dako, Carpinteria, CA, rabbit poly-
clonal) and CD8 (directly conjugated to FITC, Becton Dick-
inson) were applied singly or together for 1 h. The tissues
were then washed and incubated with anti-rabbit Alexa 488
(Molecular Probes, Eugene, OR) when using only CD3 or
anti-rabbit Alexa 568 when using both CD3 and CD8.
Tissues were then washed, mounted on a glass slide with
anti-fading medium (Vectashield, Vector Laboratories, Bur-
lingame, CA), and examined by confocal microscopy.
Confocal microscopy was performed using a Leica TCS
SP laser scanning microscope equipped with three lasers
(Leica Microsystems, Exton, PA). Individual optical slices
represent 0.2 Am and 20–60 optical slices were collected at
512  512 pixel resolution. The fluorescence of individual
fluorochromes was captured separately in sequential mode,
after optimization to reduce bleed-through between channels
(photomultiplier tubes) using Leica software. NIH-image
v1.62 and Adobe Photoshop v6 (Seattle, WA) software were
used to assign colors to each fluorochrome and the differ-
ential interference contrast image (gray scale). Co-localiza-
tion of antigens is indicated by the addition of colors as
indicated in figure legends.Acknowledgments
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